FDA Inspection 1008205 — Silliker, Inc.
The FDA completed an inspection of Silliker, Inc. on Mar 7, 2017 in Cypress, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cypress, CA (United States)